your market intelligence analyst
Search Results
626 results
Your search is now limited to «Company News in Cardiovascular Diseases» expert search.
Big News Network (UAE) 09/24/2020 14:05
The US Department of Justice said on Wednesday the settlement resolves allegations that Gilead improperly used the Caring Voice Coalition as a conduit to cover thousands of patients' co-payment obligations.
More from Big News Network (UAE):
FiercePharma 09/24/2020 09:41
While the federal government has been successful in inking deals with numerous biopharma companies so far, it's also sued Teva and Regeneron in recent months.
More from FiercePharma:
The acquisition of Inflazome will enable Roche to acquire full rights of its portfolio that includes clinical and preclinical orally available small molecule NLRP3 inhibitors.
More from Pharmaceutical Business Review: 09/22/2020 01:32
Pune, Maharashtra, India, September 22 2020 (Wiredrelease) MarketResearch.Biz –:The recent report posted via MarketResearch.Biz on Anti-Hypertensive Drugs and Therapeutics market offers critical market insights in conjunction with targeted segmentation evaluation.
More from
Updated Date: Fri, 18 Sep 2020 00:00:00 EDT.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PR Newswire 09/17/2020 08:16
Mene Pangalos , Executive Vice President, BioPharmaceuticals R&D, AstraZeneca said: "Raised LDL cholesterol is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide every year.
More from PR Newswire:
FierceBiotech 09/17/2020 03:09
The PCSK9 inhibitor market has to date not made good on its major sales promise, with the likes of Amgen and Sanofi in a price-cutting war for the heart drugs.
More from FierceBiotech:
AstraZeneca - Press Releases 09/17/2020 02:00
AstraZeneca acquires oral PCSK9 inhibitor programme from Dogma Therapeutics.
More from AstraZeneca - Press Releases:
Business Wire 09/15/2020 13:45
Pfizer is leading further development of vupanorsen, with a focus on cardiovascular risk reduction, and plans to initiate a Phase 2b dose-ranging study in the coming weeks.
More from Business Wire:
World Pharma News 09/09/2020 04:00
AstraZeneca is working to expedite the review of the single event to minimise any potential impact on the trial timeline.
More from World Pharma News: 09/08/2020 17:09
Genentech and Roche are investigating more than a dozen medicines for neurological disorders, including multiple sclerosis, stroke, neuromyelitis optica spectrum disorder, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, Duchenne muscular dystrophy and autism spectrum disorder.
More from
ENDPOINTS 09/08/2020 09:57
Ahead of merger with Pfizer’s generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio – Endpoints News.
More from ENDPOINTS:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications